- Article
An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
- Wojciech G. Lesniak,
- Babak Behnam Azad,
- Samit Chatterjee,
- Ala Lisok and
- Martin G. Pomper
The chemokine receptor 4 (CXCR4) is a promising diagnostic and therapeutic target for the management of various cancers. CXCR4 has been utilized in immunotherapy, targeted drug delivery, and endoradiotherapy. Poly(amidoamine) [PAMAM] dendrimers are w...

